Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-17-010704
Filing Date
2017-11-15
Accepted
2017-11-15 10:21:09
Documents
37
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPRORT sbfm_10q.htm 10-Q 556046
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF sbfm_ex311.htm EX-31.1 12719
3 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF sbfm_ex312.htm EX-31.2 11969
4 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE sbfm_ex32.htm EX-32 7199
5 IMAGE sbfm_10q000.jpg GRAPHIC 9241
6 IMAGE sbfm_10q001.jpg GRAPHIC 10558
7 IMAGE sbfm_10q002.jpg GRAPHIC 19551
8 IMAGE sbfm_10q003.jpg GRAPHIC 18270
  Complete submission text file 0001654954-17-010704.txt   1398595

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT sbfm-20170930.xml EX-101.INS 75370
10 XBRL TAXONOMY EXTENSION SCHEMA sbfm-20170930.xsd EX-101.SCH 13961
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sbfm-20170930_cal.xml EX-101.CAL 32120
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sbfm-20170930_def.xml EX-101.DEF 15800
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE sbfm-20170930_lab.xml EX-101.LAB 99152
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sbfm-20170930_pre.xml EX-101.PRE 71705
Mailing Address 469 JEAN-TALON WEST 3RD FLOOR MONTREAL A8 H3N 1R4
Business Address 469 JEAN-TALON WEST 3RD FLOOR MONTREAL A8 H3N 1R4 514-764-9698
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

EIN.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52898 | Film No.: 171204140
SIC: 8731 Services-Commercial Physical & Biological Research